BOTHELL, Wash., April 18 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. will be presenting at the UBS Global Specialty Pharmaceuticals Conference on Tuesday, April 25, 2006, at 1:00 p.m. Eastern Time at The Grand Hyatt in New York City. Steven C. Quay, M.D., Ph.D., Chairman, President and CEO of Nastech, will provide a corporate overview, including a review of the Company's product development programs.
To access the live audio webcast for this conference, please log on to Nastech's website at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.
About Nastech
Nastech is a pharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and its collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, respiratory disease and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.
CONTACTS: Nastech Pharmaceutical Company Inc. Ed Bell Senior Investor Relations Manager (425) 908-3639 ir@nastech.com Noonan Russo Matthew Haines (Investors/Media) (212) 845-4235
Nastech Pharmaceutical Company Inc.CONTACT: Ed Bell, Senior Investor Relations Manager of NastechPharmaceutical Company Inc., +1-425-908-3639, ir@nastech.com; or Investors- Media, Matthew Haines of Noonan Russo, +1-212-845-4235, for Nastech
Web site: http://www.nastech.com/
